Anixa Biosciences Revenue vs. Total Debt
| ANIX Stock | USD 3.20 0.14 4.58% |
Total Revenue | First Reported 1986-01-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 207.2 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.25 | 0.27 |
|
|
For Anixa Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Anixa Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Anixa Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Anixa Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Anixa Biosciences over time as well as its relative position and ranking within its peers.
Anixa |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anixa Biosciences. If investors know Anixa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anixa Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.39) | Return On Assets (0.35) | Return On Equity (0.55) |
The market value of Anixa Biosciences is measured differently than its book value, which is the value of Anixa that is recorded on the company's balance sheet. Investors also form their own opinion of Anixa Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Anixa Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anixa Biosciences' market value can be influenced by many factors that don't directly affect Anixa Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anixa Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anixa Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anixa Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Anixa Biosciences Total Debt vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Anixa Biosciences's current stock value. Our valuation model uses many indicators to compare Anixa Biosciences value to that of its competitors to determine the firm's financial worth. Anixa Biosciences is rated below average in revenue category among its peers. It is rated below average in total debt category among its peers making up about 0.83 of Total Debt per Revenue. The ratio of Revenue to Total Debt for Anixa Biosciences is roughly 1.20 . At this time, Anixa Biosciences' Total Revenue is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Anixa Biosciences' earnings, one of the primary drivers of an investment's value.Anixa Revenue vs. Competition
Anixa Biosciences is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 156.08 Million. Anixa Biosciences adds roughly 210,000 in revenue claiming only tiny portion of equities under Health Care industry.
Anixa Total Debt vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Anixa Biosciences |
| = | 210 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Anixa Biosciences |
| = | 175 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Anixa Total Debt vs Competition
Anixa Biosciences is rated below average in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 230.91 Million. Anixa Biosciences adds roughly 175,000 in total debt claiming only tiny portion of equities under Health Care industry.
Anixa Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Anixa Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Anixa Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Anixa Biosciences' change in net profit over the period of time. It can combine multiple indicators of Anixa Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -85.5 K | -89.8 K | |
| Operating Income | -9.9 M | -9.4 M | |
| Net Loss | -8.9 M | -9.4 M | |
| Income Tax Expense | -136.8 K | -130 K | |
| Income Before Tax | -8.9 M | -9.4 M | |
| Total Other Income Expense Net | 972.9 K | 1 M | |
| Net Loss | -8.9 M | -9.4 M | |
| Non Operating Income Net Other | 119.6 K | 125.6 K | |
| Net Loss | -12.2 M | -12.8 M | |
| Interest Income | 1.2 M | 1.3 M | |
| Net Interest Income | 1.2 M | 1.3 M | |
| Change To Netincome | 7.7 M | 3.9 M | |
| Net Loss | (0.29) | (0.30) | |
| Income Quality | 0.72 | 0.61 | |
| Net Income Per E B T | 1.14 | 1.10 |
Anixa Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Anixa Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Anixa Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Anixa Biosciences' important profitability drivers and their relationship over time.
Use Anixa Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anixa Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anixa Biosciences will appreciate offsetting losses from the drop in the long position's value.Anixa Biosciences Pair Trading
Anixa Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Anixa Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anixa Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anixa Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anixa Biosciences to buy it.
The correlation of Anixa Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anixa Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anixa Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anixa Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Anixa Biosciences position
In addition to having Anixa Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Electronic Equipment Thematic Idea Now
Electronic Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electronic Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronic Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Anixa Stock Analysis
When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.